Registry of Toxic Effects of Chemical Substances (RTECS)
Chromium(III) chloride, hexahydrate (1:3:6)
RTECS #
GB5450000CAS #
10060-12-5Updated
July 2013Molecular Weight
266.47Molecular Formula
Cl3Cr·6H2OSynonyms
Chlorid chromity hexahydrat (Czech)Chromic chloride hexahydrate
Chromium chloride, hexahydrate (8CI,9CI)
Chromium sesquichloride
Chromium trichloride hexahydrate
Hexaaquachromium (III) chloride
Hexaaquachromium chloride
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | lymphocyte/human | 2500 µg/L | MUREAV 191,207,1987 |
Cytogenetic Analysis | leukocyte/human | 400 mg/L | SAIGBL 18,136,1976 |
DNA adduct | intraperitoneal/rat | 80 mg/kg | CNREA8 45,1146,1985 |
DNA adduct | kidney/hamster | 500 mg/L | CBINA8 37,309,1981 |
DNA Damage | lung/hamster | 10 µmol/L | MUREAV 117,279,1983 |
DNA Damage | other cell types/cattle | 0.01 mmol/L/1H | EVHPAZ 108,399,2000 |
DNA repair | /Escherichia coli | 31 µg/well | MUREAV 133,161,1984 |
other mutation test systems | other cell types/human | 500 mg/L | BJCAAI 44,219,1981 |
other mutation test systems | kidney/hamster | 500 mg/L | CBINA8 37,309,1981 |
sister chromatid exchange | lung/hamster | 39 mg/L | CRNGDP 4,605,1983 |
sister chromatid exchange | fibroblast/hamster | 32 mg/L | MUREAV 104,141,1982 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/mouse | 134 mg/kg (8D pregnant) | Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material) Reproductive: Specific developmental abnormalities: Central nervous system | TXCYAC 26,257,1983 |
intraperitoneal/mouse | 266 mg/kg (1D male) | Reproductive: Other reproductive system tumors | TXAPA9 158,161,1999 |
intraperitoneal/mouse | 266.5 mg/kg (1D male) | Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females) Reproductive: Effects on newborn: Biochemical and metabolic | EVHPAZ 110,801,2002 |
intraperitoneal/mouse | 26.6 mg/kg (1D male) | Reproductive: Effects on newborn: Biochemical and metabolic | EVHPAZ 110,801,2002 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/mouse | lethal dose (50 percent kill): 285 mg/kg | TXAPA9 63,461,1982 | |
intraperitoneal/mouse | lowest published toxic dose: 266.47 mg/kg | Endocrine: Hyperglycemia Endocrine: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain | EVHPAZ 110,801,2002 |
intravenous/frog | lowest published lethal dose: 374 mg/kg | AIPTAK 62,330,1939 | |
intravenous/mouse | lowest published lethal dose: 1602 mg/kg | AIPTAK 62,330,1939 | |
intravenous/rabbit | lowest published lethal dose: 576 mg/kg | AIPTAK 62,330,1939 | |
oral/mouse | lethal dose (50 percent kill): 2.39 gm/kg | Behavioral: Alteration of classical conditioning | FCTOD7 50,1623,2012 |
oral/mouse | lowest published lethal dose: 4.8 gm/kg | Eye: Hemorrhage Behavioral: Alteration of classical conditioning | FCTOD7 50,1623,2012 |
oral/mouse | lowest published toxic dose: 2.4 gm/kg | Endocrine: Changes in spleen weight Liver: Changes in liver weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain | FCTOD7 50,1623,2012 |
oral/rat | lowest published toxic dose: 895 mg/kg | Biochemical: Metabolism (intermediary): Lipids including transport | TXCYAC 180,5,2002 |
oral/rat | lethal dose (50 percent kill): 1790 mg/kg | MarJV# 29MAR1977 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 219.8 mg/kg/2W- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | FCTOD7 50,1623,2012 |
Reviews
Organization | Standard | Reference |
---|---|---|
TOXICOLOGY REVIEW | 85DHAX Cr,22,1974 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 1 mg(Cr)/m3 | DTLVS* 3,35,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 0.5 mg(Cr)/m3, JUL2008 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 0.5 mg(Cr)/m3, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.005 mg(Cr)/m3, MAY2011 | |
Occupational Exposure Limit-EC | time-weighted average 2 mg(Cr)/m3, FEB2006 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 0.5 mg(Cr)/m3, a2 sen, s1 sen, MAY2012 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 0.5 mg(Cr)/m3, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 0.5 mg(Cr)/m3, JAN1999 | |
Occupational Exposure Limit-POLAND | time-weighted average 0.5 mg(Cr)/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | time-weighted average 0.01 mg/m3, short term exposure limit 0.03 mg/m3, JUN2003 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 0.5 mg(Cr)/m3, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.5 mg(Cr)/m3, inhal, sen, JAN2011 | |
Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 0.5 mg(Cr)/m3, OCT2007 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 0.5 mg(Cr)/m3 | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 0.5 mg(Cr)/m3 | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 0.5 mg(Cr)/m3 | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 0.5 mg(Cr)/m3 | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Status in Federal Agencies
Organization | Reference |
---|---|
EPA GENETOX PROGRAM 1988, Negative: In vivo cytogenetics-mammalian oocyte |
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division